| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 5,649,543 | 6,494,597 | 5,611,116 | | Cost of Revenue | 3,700,353 | 3,736,101 | 2,555,422 | | | Gross Profit | 1,949,191 | 2,758,496 | 3,055,694 | | | Operating Expenses | | Research Development | 18,821 | 32,621 | 14,588 | | Selling General and Administrative | 213,576 | 218,152 | 162,181 | | Non Recurring | 481,979 | 67,280 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,234,815 | 2,440,444 | 2,878,926 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (18,003) | 204,899 | 410,172 | | Earnings Before Interest And Taxes | 702,920 | 2,643,304 | 2,138,385 | | Interest Expense | 148,931 | 86,649 | 83,236 | | Income Before Tax | 553,989 | 2,556,655 | 2,055,150 | | Income Tax Expense | 538,441 | 772,705 | 1,008,268 | | Minority Interest | (67,101) | (47,912) | (28,317) | | | | Net Income From Continuing Ops | 480,342 | 1,732,980 | 2,169,277 | | | Non-recurring Events | | Discontinued Operations | (14,729) | (46,892) | 30,892 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 465,613 | 1,686,088 | 2,200,168 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $465,613 | $1,686,088 | $2,200,168 |
|
0.26% Nasdaq 
0.67 (1.77%) 
Income Statement
